Zubretsky Joseph M's Form 4 filing
Molina Healthcare, Inc. (MOH) · filed Sep 23, 2022
- Accession no.
- 0001179929-22-000143
- Filed
- Sep 23, 2022
- Trade date
- Sep 22, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $9.93M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zubretsky Joseph MCIK 0001320929 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $67.33 | +$2,019,900 | 285,157 | Direct | |
| Sep 22, 2022 | Common Stock | SSaleDisposed | −18,814 | $330.46F2 | −$6,217,274.44 | 266,343 | Direct | |
| Sep 22, 2022 | Common Stock | SSaleDisposed | −8,686 | $331.48F3 | −$2,879,235.28 | 257,657 | Direct | |
| Sep 22, 2022 | Common Stock | SSaleDisposed | −2,500 | $332.22F4 | −$830,550 | 255,157 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 257,124 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $330.00 to $330.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $331.00 to $331.99. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $332.01 to $332.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.